Tuberculosis remains the world's leading infectious killer, resulting in more than 1·25 million deaths in 2023 alone.1 During ...

A new credit card-sized tuberculosis (TB) test, requiring no electricity, could revolutionize detection in HIV hotspots by ...

World leaders are dismantling global health programs and cutting back foreign aid. Will an extraordinary new medicine be able ...

Mumbai: For the first time, select patients with drug-resistant tuberculosis (DR-TB) in the city are being treated with a new, shorter regimen that promises better outcome and fewer side-effects ...

Anyone who attended St. Michael’s Catholic Church in San Diego from September 22 to December 1, 2024, may have been exposed to drug-resistant tuberculosis (TB).

Anyone who attended St. Michael's Catholic Church in San Diego from September 22 to December 1, 2024, may have been exposed to drug-resistant tuberculosis (TB).

New Delhi: Drug-resistant tuberculosis (DR-TB) remains a formidable challenge in India's fight against TB, with multidrug-resistant (MDR-TB) and extensively drug-resistant (XDR-TB) cases on the rise.

Barack Odima is two years into treatment, relying on a rare drug for extensively drug-resistant tuberculosis. It vanished from stock at the clinic he uses, in the weeks after the U.S. funding freeze.

Dr Sandeep Sangale, joint director (TB and leprosy), Maharashtra, said, “The new drug regime has been proven to be safe, more effective and a quicker treatment option than the previous MDR-TB ...

Tuberculosis (TB), one of the leading infectious disease killers worldwide, has long posed a challenge, particularly with the rise of drug-resistant forms. However, new research offers fresh hope ...

Drug-resistant tuberculosis (TB) is a major contributor to global antimicrobial resistance with around half a million people falling ill with drug-resistant strains annually. Mycobacterium ...